23.05
price up icon1.10%   0.365
 
loading
Precedente Chiudi:
$22.69
Aprire:
$22.78
Volume 24 ore:
43,363
Relative Volume:
0.08
Capitalizzazione di mercato:
$1.56B
Reddito:
$71.30M
Utile/perdita netta:
$-354.80M
Rapporto P/E:
-4.1243
EPS:
-5.59
Flusso di cassa netto:
$-356.00M
1 W Prestazione:
-7.95%
1M Prestazione:
-10.95%
6M Prestazione:
-33.80%
1 anno Prestazione:
+10.29%
Intervallo 1D:
Value
$22.57
$23.32
Intervallo di 1 settimana:
Value
$21.17
$25.10
Portata 52W:
Value
$20.99
$53.08

Arvinas Inc Stock (ARVN) Company Profile

Name
Nome
Arvinas Inc
Name
Telefono
203-535-1456
Name
Indirizzo
395 WINCHESTER AVE, NEW HAVEN, CT
Name
Dipendente
445
Name
Cinguettio
@ArvinasInc
Name
Prossima data di guadagno
2024-10-30
Name
Ultimi documenti SEC
Name
ARVN's Discussions on Twitter

Confronta ARVN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
ARVN 23.01 1.56B 71.30M -354.80M -356.00M -5.59
VRTX 446.42 115.74B 10.63B -479.80M -1.35B 13.33
REGN 739.53 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 587.24 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 248.68 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 102.48 24.49B 3.30B -501.07M 1.03B 11.54

Arvinas Inc Stock (ARVN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-02-14 Downgrade Citigroup Buy → Neutral
2024-02-01 Iniziato Goldman Buy
2023-12-19 Aggiornamento Wells Fargo Equal Weight → Overweight
2023-12-06 Aggiornamento Jefferies Hold → Buy
2023-11-20 Aggiornamento Guggenheim Neutral → Buy
2023-10-23 Aggiornamento Wedbush Neutral → Outperform
2023-06-26 Ripresa Oppenheimer Outperform
2023-01-12 Downgrade Guggenheim Buy → Neutral
2023-01-03 Downgrade Wells Fargo Overweight → Equal Weight
2022-09-09 Iniziato Barclays Overweight
2022-06-21 Iniziato Jefferies Hold
2022-05-09 Downgrade Wedbush Outperform → Neutral
2022-04-28 Iniziato Credit Suisse Outperform
2022-04-06 Iniziato Morgan Stanley Equal-Weight
2022-02-11 Ripresa BMO Capital Markets Outperform
2022-02-10 Iniziato Wells Fargo Overweight
2022-01-19 Iniziato Goldman Buy
2021-12-07 Iniziato Cowen Outperform
2021-10-14 Iniziato SVB Leerink Outperform
2021-09-30 Iniziato Stifel Buy
2021-09-09 Iniziato BofA Securities Buy
2021-05-21 Iniziato UBS Buy
2021-04-21 Iniziato Truist Buy
2021-03-31 Iniziato BMO Capital Markets Outperform
2020-12-14 Aggiornamento Oppenheimer Perform → Outperform
2020-06-01 Aggiornamento Citigroup Neutral → Buy
2020-05-12 Iniziato Oppenheimer Perform
2019-12-19 Iniziato H.C. Wainwright Buy
2019-11-25 Iniziato Guggenheim Buy
2019-10-24 Aggiornamento Goldman Neutral → Buy
2019-09-25 Iniziato Wedbush Outperform
2019-09-12 Iniziato BMO Capital Markets Outperform
2019-08-06 Iniziato Cantor Fitzgerald Overweight
2019-06-05 Downgrade Citigroup Buy → Neutral
2019-04-12 Iniziato Evercore ISI Outperform
2018-10-22 Iniziato Citigroup Buy
2018-10-22 Iniziato Goldman Neutral
2018-10-22 Iniziato Piper Jaffray Overweight
Mostra tutto

Arvinas Inc Borsa (ARVN) Ultime notizie

pulisher
Nov 20, 2024

Arvinas stock remains a Top Pick despite slight reduction in price target, says BMO - Investing.com

Nov 20, 2024
pulisher
Nov 20, 2024

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Arvinas, Inc. (ARVN) And Encourages Stockholders to Reach Out - AccessWire

Nov 20, 2024
pulisher
Nov 20, 2024

Unveiling 4 Analyst Insights On Arvinas - Benzinga

Nov 20, 2024
pulisher
Nov 20, 2024

Arvinas shares target cut to $62 on delayed trial data - Investing.com

Nov 20, 2024
pulisher
Nov 19, 2024

Arvinas reports delay in breast cancer trial results - Investing.com India

Nov 19, 2024
pulisher
Nov 19, 2024

Arvinas, Inc. (ARVN): This Small-Cap Stock Is Ready To Explode - Insider Monkey

Nov 19, 2024
pulisher
Nov 19, 2024

Pfizer, Arvinas delay late-stage trial for breast cancer therapy - Seeking Alpha

Nov 19, 2024
pulisher
Nov 18, 2024

Stephens Begins Coverage on Arvinas (NASDAQ:ARVN) - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

Short Interest in Arvinas, Inc. (NASDAQ:ARVN) Drops By 5.6% - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

Stephens & Co. Initiates Coverage of Arvinas (ARVN) with Overweight Recommendation - MSN

Nov 18, 2024
pulisher
Nov 14, 2024

RTW INVESTMENTS, LP Adjusts Stake in Arvinas Inc - GuruFocus.com

Nov 14, 2024
pulisher
Nov 13, 2024

Arvinas chief accounting officer David Loomis sells $10,300 in stock By Investing.com - Investing.com Australia

Nov 13, 2024
pulisher
Nov 12, 2024

Arvinas chief accounting officer David Loomis sells $10,300 in stock - Investing.com

Nov 12, 2024
pulisher
Nov 10, 2024

How the (ARVN) price action is used to our Advantage - Stock Traders Daily

Nov 10, 2024
pulisher
Nov 07, 2024

Arvinas, Inc. (NASDAQ:ARVN) Receives Average Rating of “Moderate Buy” from Analysts - Defense World

Nov 07, 2024
pulisher
Nov 07, 2024

Arvinas, Inc. (NASDAQ:ARVN) Receives $56.92 Consensus Target Price from Analysts - MarketBeat

Nov 07, 2024
pulisher
Nov 06, 2024

Arvinas (ARVN) Stock Price, News & Analysis - MarketBeat

Nov 06, 2024
pulisher
Nov 05, 2024

Arvinas's SWOT analysis: biotech stock poised for pivotal trial results - Investing.com India

Nov 05, 2024
pulisher
Nov 05, 2024

Arvinas's SWOT analysis: biotech stock poised for pivotal trial results By Investing.com - Investing.com Canada

Nov 05, 2024
pulisher
Nov 04, 2024

Allspring Global Investments Holdings LLC Has $182,000 Stake in Arvinas, Inc. (NASDAQ:ARVN) - Defense World

Nov 04, 2024
pulisher
Nov 04, 2024

Arvinas to Participate in Upcoming Investor Conferences - GlobeNewswire

Nov 04, 2024
pulisher
Nov 04, 2024

Arvinas (NASDAQ:ARVN) Receives Buy Rating from HC Wainwright - Defense World

Nov 04, 2024
pulisher
Nov 04, 2024

FY2024 EPS Estimates for Arvinas Reduced by Leerink Partnrs - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Wedbush Issues Pessimistic Estimate for Arvinas Earnings - Defense World

Nov 04, 2024
pulisher
Nov 04, 2024

FY2024 EPS Estimates for Arvinas Cut by Leerink Partnrs - Defense World

Nov 04, 2024
pulisher
Nov 04, 2024

Arvinas (NASDAQ:ARVN) Price Target Lowered to $40.00 at Oppenheimer - Defense World

Nov 04, 2024
pulisher
Nov 01, 2024

Arvinas Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 01, 2024
pulisher
Oct 31, 2024

Oppenheimer cuts Arvinas shares price target to $40 ahead of TACTIVE-U trial - Investing.com

Oct 31, 2024
pulisher
Oct 31, 2024

Arvinas' (ARVN) Buy Rating Reiterated at HC Wainwright - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

Arvinas, Inc. (NASDAQ:ARVN) Q3 2024 Earnings Call Transcript - Insider Monkey

Oct 31, 2024
pulisher
Oct 31, 2024

Arvinas, Inc. (ARVN) Reports Q3 Loss, Tops Revenue Estimates - MSN

Oct 31, 2024
pulisher
Oct 31, 2024

Arvinas Inc (ARVN) Q3 2024 Earnings Call Highlights: Strong Reve - GuruFocus.com

Oct 31, 2024
pulisher
Oct 31, 2024

Assenagon Asset Management S.A. Invests $3.44 Million in Arvinas, Inc. (NASDAQ:ARVN) - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

Arvinas Inc (ARVN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Promising ... - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

Arvinas Inc (ARVN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Promising ... By GuruFocus - Investing.com Canada

Oct 31, 2024
pulisher
Oct 31, 2024

Arvinas Reports Progress in Q3 2024 Financials and Trials - TipRanks

Oct 31, 2024
pulisher
Oct 30, 2024

Arvinas Inc (ARVN) Q3 2024 Earnings: Revenue Soars to $102.4M, B - GuruFocus.com

Oct 30, 2024
pulisher
Oct 30, 2024

Arvinas (NASDAQ:ARVN) Trading 4.3% HigherTime to Buy? - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

Arvinas earnings beat by $0.16, revenue topped estimates - Investing.com Canada

Oct 30, 2024
pulisher
Oct 30, 2024

Arvinas Reports Third Quarter 2024 Financial Results and Provides Corporate Update - The Manila Times

Oct 30, 2024
pulisher
Oct 30, 2024

Arvinas, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Oct 30, 2024
pulisher
Oct 29, 2024

Arvinas Inc (ARVN) Q3 2024: Everything You Need To Know Ahead Of Earnings - GuruFocus.com

Oct 29, 2024
pulisher
Oct 29, 2024

Arvinas, Inc. (NASDAQ:ARVN) Short Interest Down 12.7% in October - MarketBeat

Oct 29, 2024
pulisher
Oct 25, 2024

We're Hopeful That Arvinas (NASDAQ:ARVN) Will Use Its Cash Wisely - Yahoo Finance

Oct 25, 2024
pulisher
Oct 23, 2024

Arvinas (ARVN): A Small-Cap Biotech with High Growth Potential - Insider Monkey

Oct 23, 2024
pulisher
Oct 23, 2024

Arvinas (ARVN) to Release Earnings on Wednesday - MarketBeat

Oct 23, 2024
pulisher
Oct 23, 2024

8 Best Small-Cap Growth Stocks to Buy According to Analysts - Insider Monkey

Oct 23, 2024
pulisher
Oct 22, 2024

Arvinas Gives Back to Local Greater New Haven Community in Third Annual Impact Day - ForexTV.com

Oct 22, 2024
pulisher
Oct 22, 2024

SG Americas Securities LLC Sells 76,236 Shares of Arvinas, Inc. (NASDAQ:ARVN) - MarketBeat

Oct 22, 2024

Arvinas Inc Azioni (ARVN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Arvinas Inc Azioni (ARVN) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Houston John G
President and CEO
Feb 23 '24
Sale
47.05
5,196
244,472
1,036,681
Cassidy Sean A
Chief Financial Officer
Feb 23 '24
Sale
47.05
1,702
80,079
181,916
Peck Ronald
Chief Medical Officer
Feb 23 '24
Sale
47.05
1,699
79,938
67,516
Taylor Ian
Chief Scientific Officer
Feb 23 '24
Sale
47.05
1,701
80,032
147,522
Taylor Ian
Chief Scientific Officer
Jan 04 '24
Option Exercise
16.00
8,252
132,032
109,973
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Capitalizzazione:     |  Volume (24 ore):